Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31737
Title: A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients.
Austin Authors: Ng, Elisabeth;Ashkar, Claudia;Seeman, Ego ;Schneider, Hans G;Nguyen, Hanh;Ebeling, Peter R;Sztal-Mazer, Shoshana
Affiliation: Department of Endocrinology & Diabetes, Alfred Health, Melbourne, Australia.
Department of Endocrinology & Diabetes, Alfred Health, Melbourne, Australia.
Department of Medicine, University of Melbourne, Melbourne, Australia.
Department of Endocrinology & Diabetes, Alfred Health, Melbourne, Australia.
Endocrinology
Department of Endocrinology, Monash Health, Clayton, Australia.
Issue Date: 2023
Date: 2022
Publication information: Osteoporosis International 2023; 34(2)
Abstract: Low serum alkaline phosphatase (ALP) was found in 9% of patients attending an osteoporosis clinic, 0.6% of hospital patients, and 2/22 with an atypical femoral fracture. Hypophosphatasia was diagnosed in 3% of osteoporosis clinic patients with low ALP. Low ALP is a screening tool for hypophosphatasia, a condition potentially aggravated by antiresorptive therapy.
URI: https://ahro.austin.org.au/austinjspui/handle/1/31737
DOI: 10.1007/s00198-022-06597-3
ORCID: 0000-0001-6649-032X
Journal: Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
PubMed URL: 36434431
ISSN: 1433-2965
Type: Journal Article
Subjects: Alkaline phosphatase
Bisphosphonate
Hypophosphatasemia
Hypophosphatasia
Osteoporosis
Appears in Collections:Journal articles

Show full item record

Page view(s)

8
checked on Sep 27, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.